ANNX - Company ID 0001528115
Annexon, Inc. trades as ANNX. This page tracks Annexon, Inc. through 492 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| Insider trade | 4 | 2026-05-13 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
| Annual report to shareholders | ARS | 2026-04-27 |
| Proxy materials | DEFA14A | 2026-04-27 |
| Proxy statement | DEF 14A | 2026-04-27 |
| PRE 14A | - | 2026-04-16 |
The largest companies sharing Annexon, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Annexon, Inc. reported a net loss of $206.70M.